Lung Adenocarcinoma
- PMID: 30137862
- Bookshelf ID: NBK519578
Lung Adenocarcinoma
Excerpt
Lung adenocarcinoma is the most common primary lung cancer seen in the United States. It falls under the umbrella of non-small cell lung cancer (NSCLC) and has a strong association with previous smoking. While incidence and mortality have declined, it remains the leading cause of cancer death in the United States. Adenocarcinoma of the lung usually evolves from the mucosal glands and represents about 40% of all lung cancers. It is the most common subtype to be diagnosed in people who have never smoked. Lung adenocarcinoma usually occurs in the lung periphery, and in many cases, may be found in scars or areas of chronic inflammation.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- Histopathology
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Surgical Oncology
- Radiation Oncology
- Medical Oncology
- Staging
- Complications
- Postoperative and Rehabilitation Care
- Consultations
- Deterrence and Patient Education
- Pearls and Other Issues
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
Similar articles
-
The role of positron computed tomography (PET/CT) in lung cancer staging.Hell J Nucl Med. 2023 May-Aug;26 Suppl:22-29. Hell J Nucl Med. 2023. PMID: 37658558
-
Influence of air quality on lung cancer in people who have never smoked.J Thorac Cardiovasc Surg. 2025 Feb;169(2):454-461.e2. doi: 10.1016/j.jtcvs.2024.06.014. Epub 2024 Jun 25. J Thorac Cardiovasc Surg. 2025. PMID: 38936598
-
Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?Clin Lung Cancer. 2017 Sep;18(5):543-550.e3. doi: 10.1016/j.cllc.2017.02.007. Epub 2017 Mar 2. Clin Lung Cancer. 2017. PMID: 28412093 Free PMC article.
-
Non-small cell lung cancer. Part I: Biology, diagnosis, and staging.Curr Probl Cancer. 1991 Mar-Apr;15(2):61-104. doi: 10.1016/0147-0272(91)90014-2. Curr Probl Cancer. 1991. PMID: 1649734 Review.
-
Non-small cell lung cancer. Part II: Treatment.Curr Probl Cancer. 1991 May-Jun;15(3):105-54. doi: 10.1016/0147-0272(91)90012-y. Curr Probl Cancer. 1991. PMID: 1713139 Review.
References
-
- Byun J, Schwartz AG, Lusk C, Wenzlaff AS, de Andrade M, Mandal D, Gaba C, Yang P, You M, Kupert EY, Anderson MW, Han Y, Li Y, Qian D, Stilp A, Laurie C, Nelson S, Zheng W, Hung RJ, Gaborieau V, Mckay J, Brennan P, Caporaso NE, Landi MT, Wu X, McLaughlin JR, Brhane Y, Bossé Y, Pinney SM, Bailey-Wilson JE, Amos CI. Genome-wide association study of familial lung cancer. Carcinogenesis. 2018 Sep 21;39(9):1135-1140. - PMC - PubMed
-
- Oh IJ, Hur JY, Park CK, Kim YC, Kim SJ, Lee MK, Kim HJ, Lee KY, Lee JC, Choi CM. Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma. Clin Lung Cancer. 2018 Sep;19(5):e775-e781. - PubMed
Publication types
LinkOut - more resources
Full Text Sources